|
|
Volumn 22, Issue 9, 2004, Pages 1085-
|
|
Does biotech M&A benefit investors?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
PRIORITY JOURNAL;
SHORT SURVEY;
BIOTECHNOLOGY;
CAPITAL FINANCING;
DRUG INDUSTRY;
INTERINSTITUTIONAL RELATIONS;
INVESTMENTS;
OWNERSHIP;
UNITED STATES;
|
|
EID: 19244365237
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0904-1085 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (1)
|
